Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Operating Expenses | 11,077 | 16,679 | 12,852 | 52,155 | 15,589 |
| Operating Income | -11,077 | -16,679 | -12,852 | -52,155 | -15,589 |
| Other Income | 1,584 | 3,912 | -1,833 | 184 | 5,122 |
| Pre-tax Income | -9,493 | -12,767 | -14,685 | -51,971 | -10,467 |
| Income Tax | -1,700 | -3,199 | -1,832 | -9,542 | -648 |
| Net Income Continuous | -7,793 | -9,568 | -12,853 | -42,429 | -9,819 |
| Net Income | $-7,793 | $-9,568 | $-12,853 | $-42,429 | $-9,819 |
| EPS Basic Total Ops | -0.47 | -0.79 | -1.35 | -5.71 | -1.62 |
| EPS Basic Continuous Ops | -0.47 | -0.79 | -1.35 | -5.71 | -1.60 |
| EPS Diluted Total Ops | -0.47 | -0.79 | -1.35 | -5.71 | -1.62 |
| EPS Diluted Continuous Ops | -0.47 | -0.79 | -1.35 | -5.71 | -1.60 |
| EPS Diluted Before Non-Recurring Items | -0.56 | -1.06 | -0.91 | -2.10 | -1.62 |
| EBITDA(a) | $-11,070 | $-16,672 | $-12,841 | $-52,031 | $-15,589 |